This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Biondvax Pharmaceuticals Ltd.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Zohar Gadri: Innovator in Influenza Vaccine Development
Introduction
Zohar Gadri is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of immunology, particularly in the development of vaccines against influenza. His innovative work has led to the creation of a unique patent that addresses critical challenges in vaccine formulation.
Latest Patents
Zohar Gadri holds a patent for "Compositions of multimeric-multiepitope influenza polypeptides and their production." This patent focuses on pharmaceutical suspensions of multimeric-multiepitope influenza polypeptides, detailing processes for their production and their use as immunizing subjects against influenza. In particular, the patent discloses stable aqueous microparticulate suspensions of a multimeric multiepitope polypeptide, which are crucial for effective vaccine delivery.
Career Highlights
Zohar Gadri is currently associated with Biondvax Pharmaceuticals Ltd., a company dedicated to advancing vaccine technology. His work at Biondvax has positioned him as a key player in the pharmaceutical industry, contributing to innovative solutions for public health challenges.
Collaborations
Throughout his career, Zohar has collaborated with esteemed colleagues such as Ram Uritski and Barry Cohen. These partnerships have fostered a collaborative environment that enhances research and development efforts in the field of vaccine technology.
Conclusion
Zohar Gadri's contributions to influenza vaccine development through his innovative patent and work at Biondvax Pharmaceuticals Ltd. highlight his commitment to improving public health. His research continues to pave the way for advancements in immunization strategies against influenza.